Cookies

Like most websites The Cannabis Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Business & Profession Business, Medical research

Cannabinoid Collaborator

What is your scientific background?

I've been in biotech and pharma for over 40 years. The discovery of monoclonal antibodies came while I was at grad school in the 1970s, and as a budding immunologist it was natural to turn my focus towards these revolutionary new therapeutics. I rode the antibody technology wave, creating tools and reagents for the immunology field – notably cytokine discovery. During the 1990s, I invented a therapeutic antibody in my lab which ultimately became a registered drug worldwide for severe asthma. Along with several other important drugs, this pushed the pharma industry into recognizing antibody therapeutics as a valid product. Today, biologics are blockbuster drugs, but initially they were treated with skepticism. Luckily, I was never afraid to go against the grain.

Read the full article now

Log in or register to read this article in full and gain access to The Cannabis Scientist’s entire content archive. It’s FREE and always will be!

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Cannabis Scientist magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

Register to The Cannabis Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Cannabis Scientist magazine

Register